$TECH News

Last published 1mo ago

1mo agoTECHBio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy DevelopmentPR NewswireInvestment strengthens Bio-Techne's global GMP manufacturing infrastructure for cell therapy applicationsNew Bristol facility expands GMP small molecule production capacity and complements recent investments in
1mo agoTECHBio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, GermanyPR NewswireBio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that...
1mo agoTECHBio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer CollaborationPR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the opening of its...
2mo agoTECHBio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate GoalsPR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced significant...
3mo agoTECHBio-Techne Corrects Dividend AnnouncementPR NewswireMINNEAPOLIS, Aug. 13, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) is issuing a correction to its dividend announcement released yesterday. The initial version incorrectly stated the shareholder of record
3mo agoTECHBio-Techne Declares DividendPR NewswireMINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2026. The quarterly
3mo agoTECHBio-Techne Releases Fourth Quarter Fiscal 2026 ResultsPR NewswireMINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ending June 30, 2026.Fourth Quarter FY2026 HighlightsFourth quarter organic
4mo agoTECHBio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein PortfolioPR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced the launch of new...
4mo agoTECHMerck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences MarketsPR NewswireMerck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation (NASDAQ: TECH), a Minneapolis-based global...
5mo agoTECHBio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar CharacterizationPR NewswireBio‑Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in mass...
6mo agoTECHBio-Techne Declares DividendPR NewswireBio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended...
6mo agoTECHBio-Techne Releases Third Quarter Fiscal 2026 ResultsPR NewswireBio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2026. Third Quarter FY2026...
6mo agoTECHBio-Techne to Present at the Bank of America Securities 2026 Global Healthcare ConferencePR NewswireBio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Bank of America...
6mo agoTECHBio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater ClarityPR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science research tools, analytical instruments, and diagnostics, today announced a...
7mo agoTECHBio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial ResultsPR NewswireBio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 6, 2026, at 8:00 a.m. ...
7mo agoTECHBio-Techne Advances Spatial Biology with Modular Expansion of COMET™ SuitePR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the expansion of...
8mo agoTECHBio-Techne to Present at Upcoming Investor ConferencesPR NewswireBio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: TD Cowen 46th Annual Health Care...
8mo agoTECHBio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical LaboratoriesPR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced that the Ella...
9mo agoTECHBio-Techne Announces Changes to its Leadership TeamPR NewswireBio-Techne Corporation (NASDAQ: TECH) today announced that Dr. Matt McManus, President of Bio-Techne's Diagnostics and Spatial Biology Segment, will...
9mo agoTECHBio-Techne Releases Second Quarter Fiscal 2026 ResultsPR NewswireBio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ending December 31, 2025. Second Quarter FY2026...
9mo agoTECHBio-Techne Declares DividendPR NewswireBio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended...
9mo agoTECHBio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic AlternativePR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the launch of...
9mo agoTECHBio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological BiomarkersPR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced the launch of...
9mo agoTECHBio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial ResultsPR NewswireBio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, February 4, 2026, at 8:00 ...
10mo agoTECHBio-Techne to Present at the 2026 J.P. Morgan Healthcare ConferencePR NewswireBio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 2026 J.P. Morgan ...
11mo agoTECHBio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial BiologyPR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced a strategic...
11mo agoTECHBio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein AnalysisPR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced the expanded...
11mo agoTECHBio-Techne to Present at Upcoming Investor ConferencesPR NewswireBio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: 8th Annual Evercore Healthcare...
11mo agoTECHBio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein PortfolioPR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced a licensing...
1y agoTECHBio-Techne to Present at Upcoming Investor ConferencesPR NewswireBio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: UBS Global Healthcare Conference...
1y agoTECHBio-Techne Releases First Quarter Fiscal 2026 ResultsPR NewswireBio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2025. First Quarter FY2026...
1y agoTECHBIO-TECHNE DECLARES DIVIDENDPR NewswireBio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended...
1y agoTECHAI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma PatientsPR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, and Nucleai, a leader in...
1y agoTECHScaleReady Announces a G-Rex® Grant has been awarded to Sonoma BiotherapeuticsPR NewswireScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Sonoma Biotherapeutics has...
1y agoTECHBio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions ResearchPR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced the launch of the...
1y agoTECHScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National HospitalPR NewswireScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, announced four G-Rex Grants have...
1y agoTECHSaguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging ReagentsBusiness WireSaguaro Biosciences, a pioneer in non-toxic live cell reagents for enhanced drug insights, announces a new distribution agreement with Bio-Techne Corporation (NASDAQ:TECH), a global provider of life science tools,
1y agoTECHBio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial ResultsPR NewswireBio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, November 5, 2025, at 8:00 ...
1y agoTECHBio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032PR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced a significant...
1y agoTECHBio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical ApplicationsPR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced new advancements in ...
1y agoTECHBio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability ReportPR NewswireBio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today released its 2025 Corporate...
1y agoTECHBio-Techne Corporation (TECH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptEarnings Call Transcripts
1y agoCNMD TECHCONMED Corporation Adds Kim Kelderman to its Board of DirectorsBusiness WireCONMED Corporation (NYSE:CNMD) today announced that Kim Kelderman will be joining its Board of Directors effective September 8, 2025. "My fellow directors and I are delighted to welcome Kim to the board," said LaVerne
1y agoTECHBio-Techne Corporation (TECH) Presents At Baird Global Healthcare Conference 2025 TranscriptEarnings Call Transcripts
1y agoTECHScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in CaliforniaPR NewswireScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that eight (8)...
1y agoTECHBio-Techne Corporation (TECH) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptEarnings Call Transcripts
1y agoTECHBio-Techne to Present at Upcoming Investor ConferencesPR NewswireBio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: 2025 Wells Fargo Healthcare...
1y agoTECHScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences LaboratoryPR NewswireScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that the Translational Sciences...
1y agoTECHBio-Techne Corporation (TECH) Q4 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoTECHBio-Techne Releases Fourth Quarter Fiscal 2025 ResultsPR NewswireBio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2025. Fourth Quarter FY2025...